Trial · NCT07912060
Integrated Feldenkrais Method With and Without DNS for Chronic Low Back Pain in Females
NCT07912060, Not applicable, Active not recruiting, University of Management and Technology Lahore
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Integrated Feldenkrais Method With and Without DNS for Chronic Low Back Pain in Females. Trials, record NCT07912060. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07912060
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Integrated Feldenkrais Method With and Without DNS for Chronic Low Back Pain in Females
- NCT number
- NCT07912060
- Status
- Active not recruiting
- Phases
- Not applicable
- Enrollment
- 60 participants, actual
- Lead sponsor
- University of Management and Technology Lahore
- Conditions
- Chronic Low Back Pain (CLBP)
- Interventions
- Integrated Feldenkrais Method with Dynamic Neuromuscular Stabilization exercises DNS, Feldenkrais Method Alone
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pain by Numeric Pain Rating Scale | At baseline and after 6 weeks | The NPRS is an 11-point numeric scale ranging from 0 to 10 used to assess pain intensity. With 0 representing No pain, 1-3 representing Mild Pain (nagging, annoying, interfering little with ADLs), 4-6 representing Moderate Pains (interferes significantly with ADLs), 7-10 representing Sever Pain (disabling, unable to perform. |
| Primary | Disability by Modified Oswestry Disability Index (MODI) | At baseline and after 6 weeks | Functional disability will be assessed using the Modified Oswestry Disability Index (MODI), which evaluates the impact of low back pain on daily activities and functional abilities. The questionnaire assesses limitations in activities such as personal care, lifting, walking, sitting, standing, and other everyday tasks. Changes in MODI scores will indicate improvements or changes in disability following treatment. |
| Primary | Quality of Life by 12-Item Short Form Health Survey (SF-12) | At baseline and after 6 weeks | Quality of life will be assessed using the 12-Item Short Form Health Survey (SF-12), which measures participants' perceived physical and mental health status. It evaluates aspects of physical functioning, role limitations, bodily pain, general health, vitality, social functioning, and emotional and mental health. Changes in SF-12 physical and mental component scores will be used to assess the effects of the interventions on participants' quality of life. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07912060
GET https://conductscience.org/api/trials/v1/NCT07912060/registered